관련문헌 등
·EMEA/CPMP (INN)clozapine 2002, 4.2 Posology and method of administration
·Harrison's Principles of Internal Medicine, 20e, 2018
·Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e, 2018
·Principles and Practice of Movement Disorders, 2nd ed, 2011
·Current Medical Diagnosis & Treatment 2019
·NICE Clinical guideline. Parkinson’s disease in adults Published: 19 July 2017
·Amertican Academy of Neurology: Parkinsons’s Disease Quality Measurement Set Update, 2015
·Canadian Guidelines on Parkinson’s Disease, Can J Neurol Sci. 2012;39: Suppl 4: S1-S30
·Diagnosis and pharmacological management of Parkinson’s disease A national clinical guideline, SIGN(Scottish Intercollegiate guidelines Network), 2010
·Clinical Practice Guideline for the Management of Patients with Parkinson’s Disease, Clinical practice guidelines in the Spanish NHS (2014)
·Frieling H et al. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis. Eur Neuropsychopharmacol. 2007 Feb;17(3):165-71. Epub 2006 Oct 27.
·Merims D et al., Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Clin Neuropharmacol. 2006 Nov-Dec;29(6):331-7.
·Morgante L et al. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. Clin Neuropharmacol. 2004 Jul-Aug;27(4):153-6.
·Pollak P et al. Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry. 2004 May;75(5):689-95.